TCTR20201020002招募中2 期
Efficacy of platelet rich plasma in dry eye patients who had not responded to autologous serum treatment
Ratchadaphaiseksomphot fund0 个研究点目标入组 25 人开始时间: 2020年10月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Aged 18-80 years
- •OSDI scores at least 13 with corneal staining > 5 spots or tear break-up time < or = 5 seconds in patients treated with autologous serum at least 3 months
排除标准
- •Lid problems including lagophthalmos, ectropion, entropion trichiasis, distichiasis, epiblepharon
- •Previuos history of ocular infection in 3 months
- •Possibility to have problem with follow-up
- •Possibility to have problem with applying platelet rich plasm
- •Herpetic keratitis
- •Thrombocytopenia, sepsis, chronic liver disease, anti-coagulation therapy including warfarin, dabigatran, heparin
- •Hb < 11 mg/dl or Hct < 33% or platelet < 140,000 cell/mm2
- •History of ocular surgery within 1 month
研究者
相似试验
已完成
3 期
Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry EyeSjogren SyndromeDry EyeNCT02257957Universidad Nacional de Colombia30
尚未招募
3 期
Platelet Rich Plasma in Corneal Surface DiseasesPersistent Corneal Epithelial DefectsDry EyeNCT05320172Assiut University70
已完成
2 期
Ocular Surface Syndrome Post-lasik, Outcomes of Treatment With Platelet Rich PlasmaDry Eye After LASIK-Laser in Situ KeratomileusisNCT03322917Vissum, Instituto Oftalmológico de Alicante80
尚未招募
2 期
Effectiveness of Platelet Rich Plasma vs dermal fillers for the improvement of deep nasolabial folds - A triple blinded randomised control trialCTRI/2022/06/043452Soya Alfred Xavier
Unknown
4 期
Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface DiseaseOcular Surface DiseaseDry Eye SyndromesNCT04608084University Health Network, Toronto100